JP2024534847A5 - - Google Patents
Info
- Publication number
- JP2024534847A5 JP2024534847A5 JP2024513196A JP2024513196A JP2024534847A5 JP 2024534847 A5 JP2024534847 A5 JP 2024534847A5 JP 2024513196 A JP2024513196 A JP 2024513196A JP 2024513196 A JP2024513196 A JP 2024513196A JP 2024534847 A5 JP2024534847 A5 JP 2024534847A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- hcdr2
- hcdr1
- hcdr3
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111004998.9 | 2021-08-30 | ||
| CN202111004998 | 2021-08-30 | ||
| PCT/CN2022/115590 WO2023030272A1 (zh) | 2021-08-30 | 2022-08-29 | 抗gprc5d抗原结合蛋白及其用途 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024534847A JP2024534847A (ja) | 2024-09-26 |
| JP2024534847A5 true JP2024534847A5 (enExample) | 2025-03-14 |
Family
ID=85410857
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024513196A Pending JP2024534847A (ja) | 2021-08-30 | 2022-08-29 | 抗ｇｐｒｃ５ｄ抗原結合タンパク質とその使用 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20240384001A1 (enExample) |
| EP (1) | EP4397686A4 (enExample) |
| JP (1) | JP2024534847A (enExample) |
| CN (1) | CN116063500A (enExample) |
| WO (1) | WO2023030272A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023134718A1 (zh) * | 2022-01-14 | 2023-07-20 | 原启生物科技(上海)有限责任公司 | 靶向gprc5d的嵌合抗原受体及其用途 |
| KR20250164808A (ko) * | 2023-03-22 | 2025-11-25 | 바이오프런트 쎄라퓨틱스 (베이징) 컴퍼니 리미티드 | Gprc5d에 결합하는 나노바디 및 이의 용도 |
| WO2025011462A1 (en) * | 2023-07-07 | 2025-01-16 | Overland Therapeutics (Us) Inc. | Single domain antibodies for gprc5d |
| US12286475B2 (en) | 2023-07-31 | 2025-04-29 | Sanofi | Anti-GPRC5D antibodies and compositions |
| CN120005019A (zh) * | 2023-11-14 | 2025-05-16 | 成都优赛诺生物科技有限公司 | 一种靶向gprc5d的单域抗体、嵌合抗原受体及其应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112017011932A8 (pt) * | 2014-12-05 | 2022-11-08 | Memorial Sloan Kettering Cancer Center | Anticorpos direcionados a receptor acoplado a proteína g e métodos de uso |
| CN118271463A (zh) | 2014-12-05 | 2024-07-02 | 纪念斯隆-凯特琳癌症中心 | 靶向g-蛋白偶联受体的嵌合抗原受体及其用途 |
| TWI781108B (zh) * | 2016-07-20 | 2022-10-21 | 比利時商健生藥品公司 | 抗ｇｐｒｃ５ｄ抗體、結合ｇｐｒｃ５ｄ與ｃｄ３之雙特異性抗原結合分子及其用途 |
| SG11201907321TA (en) * | 2017-02-07 | 2019-09-27 | Daiichi Sankyo Co Ltd | Anti-gprc5d antibody and molecule comprising the antibody |
| TWI829667B (zh) * | 2018-02-09 | 2024-01-21 | 瑞士商赫孚孟拉羅股份公司 | 結合gprc5d之抗體 |
| WO2019184886A1 (zh) * | 2018-03-26 | 2019-10-03 | 上海原能细胞医学技术有限公司 | 促进免疫细胞增殖的方法 |
| EP3873937A2 (en) * | 2018-11-01 | 2021-09-08 | Juno Therapeutics, Inc. | Chimeric antigen receptors specific for g protein-coupled receptor class c group 5 member d (gprc5d) |
| CN114174338A (zh) * | 2019-07-31 | 2022-03-11 | 豪夫迈·罗氏有限公司 | 与gprc5d结合的抗体 |
| EP4069742A1 (en) * | 2019-12-06 | 2022-10-12 | Juno Therapeutics, Inc. | Anti-idiotypic antibodies to gprc5d-targeted binding domains and related compositions and methods |
-
2022
- 2022-08-29 WO PCT/CN2022/115590 patent/WO2023030272A1/zh not_active Ceased
- 2022-08-29 JP JP2024513196A patent/JP2024534847A/ja active Pending
- 2022-08-29 EP EP22863407.7A patent/EP4397686A4/en active Pending
- 2022-08-29 US US18/687,695 patent/US20240384001A1/en active Pending
- 2022-08-29 CN CN202211041811.7A patent/CN116063500A/zh active Pending